Skip to main content
Swing Capital

Nephrocare Health Services Ltd

NSE: NEPHROPLUS BSE: 544647

Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.[1]

₹642
52W: ₹445 — ₹659
PE 186 · Book ₹0 · +0% vs book
Market Cap₹6,438 Cr
Stock P/E186Price to Earnings
ROCE9.56%Return on Capital
ROE7.29%Return on Equity
Div. Yield0%Face Value ₹2

Strengths

  • +Company has reduced debt.
  • +Company's working capital requirements have reduced from 78.7 days to 61.9 days

Weaknesses

  • −Company has a low return on equity of 1.79% over last 3 years.

Shareholding Pattern

Promoters63.85%
FIIs9.94%
DIIs8.64%
Public17.56%
CategoryDec 2025Mar 2026
Promoters63.85%63.85%
FIIs9.3%9.94%▲0.6
DIIs8.1%8.64%▲0.5
Public18.74%17.56%▼1.2

Financial Statements

MetricDec 2024Sep 2025Dec 2025
Sales138.21155.92160.66
Expenses115.76132.45137.79
Operating Profit22.4523.4722.87
OPM %16.24%15.05%14.24%
Net Profit8.12-32.418.45
EPS ₹38.97-17.920.84

AI Insights

Revenue Trend

Mar 2025 revenue at ₹544Cr, up 24.8% YoY. OPM at 17%.

Debt Position

Borrowings at ₹127Cr. Debt-to-equity ratio: 0.24x. Healthy balance sheet.

Capex Cycle

CWIP at ₹4Cr (2% of fixed assets). Moderate ongoing capital expenditure.

Margin & Efficiency

ROCE improving from 0% (Mar 2021) to 10% (Mar 2025). Working capital days: 62.

Valuation

PE 186x with 9.56% ROCE. Price is N/A% above book value of ₹0. Dividend yield: 0%.

Recent Announcements